Patient leaflet - RENNIE DUAL ACTION CHEWABLE TABLETS, RENNIE EXTRA TABLETS
2. what you need to know before you take rennie dual action tablets
Do not take Rennie Dual Action Tablets:
- If you have severe kidney disease or suffer from kidney stones.
- If you have high calcium or low phosphate levels in the blood.
- If you are allergic to any of the ingredients.
Warnings and precautions:
As with other antacid products, taking these tablets can mask the symptoms of other, more serious, underlying medical conditions. If symptoms persist after fourteen days consult your doctor.
Please consult your doctor or pharmacist before taking Rennie Dual Action Tablets if you have any kidney problems, havebeen diagnosed with sarcoidosis (inflammation disease that affects multiple organs inthe body), or suffer from severe or chronic gastro-intestinal symptoms or diseases.
Other medicines and Rennie Dual Action Tablets:
- Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
- If taking antibiotics (tetracyclines, quinolones), cardiac glycosides (digoxin, digitoxin), bisphosphonates (used for the treatment of osteoporosis), dolutegravir (an anti-retroviral medicine used for the treatment of HIV infection), levothyroxine (a thyroid hormone), eltrombopag (a medicine used to increase the number of platelets) or other prescribed medicines (e.g. fluorides, phosphate, iron containing products) speak to your doctor before taking Rennie Dual Action Tablets because it can affect how these medicines work. To maximise the benefit of all medicines being used, take Rennie Dual Action Tablets 1 to2 hours after taking any other medicines.
- If you are taking any thiazide diuretics (e.g. bendroflumethiazide), which are used to increase urine production, then you should tell your doctor before taking the product because he or she may want to monitor the calcium levels in your blood.
3. HOW TO TAKE RENNIE DUAL ACTION TABLETS
Always take Rennie Dual Action Tablets exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Adults and children over 12 only: 2 tablets to be chewed, preferably 1 hour after meals and before bedtime. For heartburn an extra 2 tablets may be taken between these times. Do not take more than 12 tablets in 24 hours.
Rennie Dual Action Tablets can be used during pregnancy and breast feeding if taken as instructed above.
If symptoms persist after 14 days consult your doctor in order to exclude a more serious disease. Prolonged use should be avoided. Donotgiveto children under the age of 12.
If you take more Rennie Dual Action Tablets than you should: Drink plenty of water and consult your doctor or pharmacist. Symptoms of an overdose include nausea and vomiting, constipation, tiredness, increased urine production, increased thirst, dehydration and abnormal muscular weakness.
If you have any questions on the use of this product, ask your doctor or pharmacist.
If you forget to take Rennie Dual Action Tablets: Do not take a double dose to make up for a forgotten dose.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects are unlikely at the recommended dose.
Rarely allergic reactions to ingredients have been reported, e.g rashes, itching, difficulty in breathing and swelling of the face, mouth or throat and anaphylactic shock. If you experience these reactions stop treatment immediately and seek medical advice.
Long term use of high doses can cause high blood levels of calcium and magnesium, especially in people with kidney conditions. This can cause nausea and vomiting, upset stomach, diarrhoea, tiredness, muscular weakness, confusion, increased urine production, increased thirst and dehydration.
Taking Rennie Dual Action Tablets with milk or dairy products over a long period of time may cause milk alkali syndrome, which can cause high blood levels of calcium. Specific symptoms of milk alkali syndrome may include impaired sense of taste, headache, kidney problems, fatigue and lumps under the skin.
Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
5. how to store rennie dual action tablets
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and foil after “EXP”. The expiry date refers to the last day of that month.
Do not store above 30°C. Store in the original package in order to protect from moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. contents of the pack and other information
What Rennie Dual Action Tablets contain:
The active substances are calcium carbonate (625mg), magnesium carbonate (73.5mg) and alginic acid (150mg).
The other ingredients are: sodium hydrogen carbonate, sucrose, glucose monohydrate, povidone, talc, magnesium stearate, dextrates, saccharin sodium, lemon cream flavour (contains lemon oil, lime oil, orange oil, l-menthole, vanilline, maltodextrin, gum arabic, ascorbic acid, butylhydroxyanisol), peppermint flavour (contains peppermint oil, maltodextrin, gum arabic, silicon dioxide).
What Rennie Dual Action Tablets look like and contents of the pack:
Rennie Dual Action Tablets are off white, speckled circular chewable tablets, flat on both sides with a bevelled edge.
They are supplied in foil strips in a carton with this leaflet.
The tablets are available in pack-sizes of 12, 18, 24, 30, 36 and 48.
Not all pack sizes may be marketed.
ARTWORK APPROVAL PANEL
Marketing Authorisation Holder
Bayer plc
400 South OakWay
ReadingRG26AD
UK
This leaflet was last revised in August 2020.
Manufacturer
Delpharm Gaillard 33 rue de l’Industrie 74240Gaillard
France
Bayer
Packaging Site Approval:
| Name: | |
| Date: | |
| Action: |
Country Approval:
| Name: | |
| Date: | |
| Action: |